New Printing Format for ASU medicines will be implemented from 1st January 2018

  • News
  • November 22, 2017

The provisions have been revised by the Union Ministry of Ayush has revised the provisions for the printing of manufacturing and expiry dates of Ayurveda, Siddha, and Unani (ASU) medicines. The format needs to be implemented on all labels of the ASU drugs from 1st January 2018.

According to the new proposed format on primary and secondary labels/packs of Ayurveda, Siddha and Unani medicines to write the ‘date of manufacture’ and ‘date of expiry’ on the shall be displayed in the ‘numerical month and year i.e. MM/YYYY format’.

In Precise format, the month will be printed as two digits and the year as four digits with a slash (/) in between. For example, for a medicine manufactured in March 2018, the manufacturing date shall be written as ‘03/2018’.

Batches of Ayurveda, Siddha and Unani drugs that are already manufactured will not affect and the new provision according to the Ministry of Ayush is effective from 1st January 2018 and available in the market. The notice was sent to all licensed ASU drug manufacturers and the concerned regulatory personnel for compliance and enforcement respectively. The circular has been sent to regulators of all state departments of Ayush and related offices.

The format of the month will be printed using the capital font of first three alphabets followed by a full stop and the year as four digits, both separated by a slash.

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Max Healthcare Foundation announces fourth edition of Max Medical Scholarship Programme

    Max Healthcare Foundation announces fourth edition of Max Medical Scholarship Programme

    CDSCO warns against sales of unauthorised toxic cosmetics products from Pakistan

    CDSCO warns against sales of unauthorised toxic cosmetics products from Pakistan

    Large stock of counterfeit medicines seized from private facility in Bengaluru

    Large stock of counterfeit medicines seized from private facility in Bengaluru

    Punjab’s Drugs Challenge Shifts, Other States Blamed For Pharma Smuggling

    Punjab’s Drugs Challenge Shifts, Other States Blamed For Pharma Smuggling

    Spurious drug probe: SIT raids medical store in Bengaluru, detains proprietor

    Spurious drug probe: SIT raids medical store in Bengaluru, detains proprietor

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome